Dr Fei Sim’s vision for scope of practice

0
PSA's National President Dr Fei Sim FPS discusses the enormous changes that could come out of the scope of practice review.

Take Home Naloxone is becoming embedded in pharmacy practice

0
This International Overdose Awareness Day, pharmacists share how the Take Home Naloxone Program is helping to save patients’ lives.

Achieving gender equity in the pharmacy profession

0
To mark International Women’s Day on 8 March, two pharmacists discuss their careers and the biases that must be broken to ensure women can succeed.

Limited evidence for medicinal cannabis in most mental health conditions

0
A systematic review and meta-analysis found little evidence that cannabinoids improve outcomes for common conditions such as anxiety, post-traumatic stress disorder (PTSD) and other psychiatric disorders.

How you can help advocate for better pharmacist remuneration

0
On top of a harrowing few years working through the pandemic, it’s time pharmacists were fairly remunerated for their time and expertise. PSA needs your help to get the message across.

Chlorpromazine: from antihistamine to antipsychotic

0
While chlorpromazine’s use on people with schizophrenia has been overtaken by atypical antipsychotics, it is still used widely.